JPMorgan Chase & Co’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
15,599
-24,101
| -61% | -$385K | ﹤0.01% | 4372 |
|
|
2025
Q1 | $604K | Buy |
39,700
+24,995
| +170% | +$380K | ﹤0.01% | 3913 |
|
|
2024
Q4 | $298K | Sell |
14,705
-99
| -0.7% | -$2.01K | ﹤0.01% | 4376 |
|
|
2024
Q3 | $381K | Buy |
14,804
+2,100
| +17% | +$54K | ﹤0.01% | 4179 |
|
|
2024
Q2 | $163K | Buy |
12,704
+6,574
| +107% | +$84.5K | ﹤0.01% | 4368 |
|
|
2024
Q1 | $140K | Buy |
6,130
+1,622
| +36% | +$37.1K | ﹤0.01% | 4602 |
|
|
2023
Q4 | $118K | Sell |
4,508
-34,305
| -88% | -$898K | ﹤0.01% | 4694 |
|
|
2023
Q3 | $1.09M | Sell |
38,813
-6,490
| -14% | -$182K | ﹤0.01% | 3351 |
|
|
2023
Q2 | $1.38M | Buy |
45,303
+43,469
| +2,370% | +$1.32M | ﹤0.01% | 3238 |
|
|
2023
Q1 | $34K | Buy |
1,834
+461
| +34% | +$8.55K | ﹤0.01% | 5014 |
|
|
2022
Q4 | $14K | Sell |
1,373
-138
| -9% | -$1.41K | ﹤0.01% | 5053 |
|
|
2022
Q3 | $40K | Buy |
1,511
+142
| +10% | +$3.76K | ﹤0.01% | 4764 |
|
|
2022
Q2 | $62K | Sell |
1,369
-114
| -8% | -$5.16K | ﹤0.01% | 4796 |
|
|
2022
Q1 | $146K | Buy |
1,483
+309
| +26% | +$30.4K | ﹤0.01% | 4590 |
|
|
2021
Q4 | $179K | Buy |
1,174
+566
| +93% | +$86.3K | ﹤0.01% | 4596 |
|
|
2021
Q3 | $82K | Sell |
608
-705
| -54% | -$95.1K | ﹤0.01% | 4808 |
|
|
2021
Q2 | $193K | Buy |
+1,313
| New | +$193K | ﹤0.01% | 4516 |
|